MedTrace Logo

Clinical Study Evaluating Vildagliptin Versus Vildagliptin/Metformin on NAFLD With DM

NCT03925701 · Status: RECRUITING · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2019-04-29

No results posted yet for this study

Summary

Clinical study evaluating vildagliptin versus vildagliptin/metformin on NAFLD with DM.

Conditions

  • dm

Interventions

DRUG

Vildagliptin

vildagliptin twice daily

DRUG

vildagliptin\metformin

vildagliptin\\metformin twice daily

Sponsors & Collaborators

  • Sherief Abd-Elsalam

    lead OTHER

Principal Investigators

  • Aya G Moussa, Msc · Tanta University - Faculty of Pharmacy

  • Osama M Ibrahim, Prof · Prof of Clinical Pharmacy

  • Gamal Alazab, ass. Prof. · Prof of Clinical Pharmacy

  • Yasser Abdel Raouf, Ass Prof · Tanta University-Faculty of Medicine

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-04-01
Primary Completion
2028-12-31
Completion
2028-12-31

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03925701 on ClinicalTrials.gov